loader from loading.io

In the News.. CGM Disqualifies High School Swimmer, Dexcom Smoothing, T2 Remission and more!

Diabetes Connections | Type 1 Diabetes

Release Date: 09/03/2021

In the News.. Tzield approved for toddlers, generic Ozempic, Omnipod & Tandem updates, T1D Barbie honored... and more! show art In the News.. Tzield approved for toddlers, generic Ozempic, Omnipod & Tandem updates, T1D Barbie honored... and more!

Diabetes Connections | Type 1 Diabetes

It's In The News - where we bring you the top diabetes stories and headlines happening now. This week, Tzield approved down to age one and over, Omnipod trials for fully closed loop, Tandem approved for pregnancy, Eversense 365 launches in Europe, generic Ozempic in Canada, an award for the T1D Barbie and more.  Announcing Community Commericals! Learn how to Don't miss our in-person events:   Learn more about Please visit our Sponsors & Partners - they help make the show possible!  from extreme temperatures The best way to keep up with Stacey and...

info_outline
Inside Tandem’s Next Chapter:  Tubeless Mobi, 7-Day Wear & More with VP of Product Management Marisa Fienup show art Inside Tandem’s Next Chapter: Tubeless Mobi, 7-Day Wear & More with VP of Product Management Marisa Fienup

Diabetes Connections | Type 1 Diabetes

This week on Diabetes Connections.. an update from Tandem Diabetes. Quite a few approvals and advances have already happened for Tandem this year, as the company looks ahead to the launch of their latest product, the Mobi Tubeless, not yet FDA approved. I’m talking to Marisa Fienup VP of Product Management about how this product is different from the original Mobi, the incorporation of the approved 7-day infusion set, asking your questions and more. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing...

info_outline
The Fight to Save Levemir: Inside the Grassroots Push to Protect Insulin Choice show art The Fight to Save Levemir: Inside the Grassroots Push to Protect Insulin Choice

Diabetes Connections | Type 1 Diabetes

In 2024 Novo Nordisk announced it would discontinue Levimir insulin.. leaving many people scrambling and kind of stunned. There’s no other insulin on the market quite like this long-acting – and it turns out the community wasn’t letting it go without a fight. My guests are going to tell you more about why. I’m taking to Alison Smart, founder of Choice – her daughter lives with type 1 as well as two doctors: Florence Brown and Amy Valent. Dr. Brown is Co-Director Joslin and BIDMC Diabetes in Pregnancy Program, Assistant Professor of Medicine, Harvard Medical School. Dr. Valent...

info_outline
BONUS Episode: TempraMed wants to pair smart insulin  tracking with temperature protection show art BONUS Episode: TempraMed wants to pair smart insulin tracking with temperature protection

Diabetes Connections | Type 1 Diabetes

I’ve been talking to the folks at VIVI Cap for a few years now, it’s been fun watching their progress. I wanted to catch up and find out more about what they’ve been up to when it comes to insulin storage  – especially as we get closer to the hot summer months. They launched new products in the last year – smart insulin storage that helps you track dosing and a new case with more cooling protection. My guest is Ron Nagar, the founder and CEO of TempraMed, the company that makes the VIVI Cap. This podcast is not intended as medical advice. If you have those kinds of questions,...

info_outline
In the News.. Stem Cell Research Update, New Patch Pump Approved, GLP-1 Resistance Studied, Big Win T1D School Kids and more! show art In the News.. Stem Cell Research Update, New Patch Pump Approved, GLP-1 Resistance Studied, Big Win T1D School Kids and more!

Diabetes Connections | Type 1 Diabetes

It's In the News! Every other week we bring you the top diabetes stories and headlines happening now. This week's top stories: stem cell reserach updates, the Pivot patch pump gets FDA approval, GLP-1 Resistance research moves forward, T1D kids in VA get a big win, time of day for exercise matters, and much more! Don't miss our 2026 events - Announcing Community Commericals! Learn how to Learn more about  Please visit our Sponsors & Partners - they help make the show possible!  from extreme temperatures The best way to keep up with Stacey and the show...

info_outline
Eversense 365: Pump Integration and Real-Life Use For the One-Year CGM show art Eversense 365: Pump Integration and Real-Life Use For the One-Year CGM

Diabetes Connections | Type 1 Diabetes

We've got an update on Eversense—the CGM that sits just below the skin and lasts a year. This is the first time we’re talking to the folks from Senseonics, the company that makes Eversense, since they spun off from Ascensia. What's changed? It’s also the first time, we’re talking to someone who uses Eversense with an insulin pump – it’s now compatible with the twiist pump. I ask your questions about all of this – how’s the pump integration in real life, when will the next iterations of Eversense be out, their success in the type 2 market and much more. We're talking to Chief...

info_outline
More Than Babysitting: The Power of Type One Together with Raquel Baron show art More Than Babysitting: The Power of Type One Together with Raquel Baron

Diabetes Connections | Type 1 Diabetes

Today on Diabetes Connections.. a bonus episode all about finding support and community online and in real life. Seems to be a theme lately and I could NOT be happier. Type One Together started with one college student, a few babysitting jobs, and a realization that there was a need. Type One Together has become something much bigger – they’ll still help you find a sitter but they’re also a hub for T1D info, support and gatherings. I’m talking to the founder, Raquel Baron, about how they got there, what kind of help they provide and what’s next. This podcast is not intended as...

info_outline
In the News... Insulin Act, weekly basal approved, weight loss pill okayed, gene therapy for T1D and more! show art In the News... Insulin Act, weekly basal approved, weight loss pill okayed, gene therapy for T1D and more!

Diabetes Connections | Type 1 Diabetes

It's In the News, a look at the top headlines and stories in the diabetes community. This week's top stories: Senate Insulin Act moves forward, FDA approveds Awiqli for type 2 and and second oral GLP-1 pill, lots of updates on stem cell and gene therapy for type 1, updates from Beta Bionics, veterans group and Dexcom team up, and Omnipod features on Scrubs. Much more in the episode! Announcing Community Commericals! Learn how to  Learn more about  Please visit our Sponsors & Partners - they help make the show possible!  from extreme temperatures The best way...

info_outline
Grownup T1Ds: The Missing Support for Adults Living with Diabetes show art Grownup T1Ds: The Missing Support for Adults Living with Diabetes

Diabetes Connections | Type 1 Diabetes

There’s a reason we don’t call it juvenile diabetes anymore. We all know you grow up and T1D doesn’t go anywhere, and that you can be diagnosed at any age. But it often feels like adults are forgotten. I hope that’s not the case here—but I hear it all the time in the broader community. Kelly Dawes is working to change that. She’s started GrownUp T1Ds, a community built specifically for adults who’ve been living with type 1 for years and are finally finding connection, understanding, and support in a way they may never have had before. This podcast is not intended as medical...

info_outline
In the News... the In the News... the "Next Ozempic" moves forward, diabetes and dementia link, tech updates & approvals, ATTD news and more

Diabetes Connections | Type 1 Diabetes

It's In the News, a look at the top headlines and stories in the diabetes community. This week's top stories: Metformin may help stem macular degeneration, retatutride moves forward, T1D and demntia link studied, lots of news from ATTD and more! Announcing Community Commericals! Learn how to  Learn more about  Please visit our Sponsors & Partners - they help make the show possible!  from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Here's where to find us: Learn more about...

info_outline
 
More Episodes

This week "In the News.." Did wearing a CGM in the water disqualify a high school swimmer? What his family says happened and why they're suing. The ADA wants to start using the word "remission" instead of "reversed" for type 2 diabetes - we'll talk about why. Dexcom says they are no long smoothing data, new migraine and diabetes research and T1Interntioanl is out with their latest survey results about the price and use of insulin.

Join us Live on Facebook each Wednesday at 4:30pm EDT!

Check out Stacey's book: The World's Worst Diabetes Mom!

Join the Diabetes Connections Facebook Group!

Sign up for our newsletter here

-----

Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----

Get the App and listen to Diabetes Connections wherever you go!

Click here for iPhone      Click here for Android

Episode transcript below

 

Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days.  As always, I’m going to link up my sources in the Facebook comments - where we are live - and in the show notes at d-c dot com when this airs as a podcast.. so you can read more if you want, whenever you want.

XX

In the News is brought to you by Real Good Foods! Find them in your local grocery store, Target or Costco. Real Food You Feel Good About Eating.

XX

Top story this week.. A discrimination complaint against the Colorado High School Activities Association has been filed with the U.S. Department of Justice. At issue? A student was disqualified for wearing his continuous glucose monitor.  Ethan Orr is a 16-year-old swimmer whose team qualified for the state championships.

According to his attorney Orr wore a blood glucose monitor taped to his arm during seven prior matches, including the one in which his team qualified for the state championships, with no issue.

But at this meet, the ref said Orr would not be allowed to swim in his last race because of his glucose monitor and tape. They didn’t have a sub so the whole team was disqualified.

The attorney says, “This is simply blatant discrimination against a kid with a disability, and it led to unnecessary and unfair consequences to him, his teammates, and the school,”

According to the lawsuit, Orr is protected under two federal laws - the Americans with Disabilities Act and Section 504 of the Rehabilitation Act of 1973.

I’ve reached out to the local reporter on this story and hope to talk to the family soon

XX

People with type 2 diabetes should be considered in remission after sustaining normal blood glucose levels for three months or more without medication. That’s a new consensus statement from the American Diabetes Association® and several other international groups.

They recommend testing every year to determine long term maintenance.

The real news here - as I see it - is trying to get people to stop saying “Reversal” or “cure” when it comes to diabetes. The statement here doesn’t seem to be about the science, but says the word remission “strikes an appropriate balance” between the diabetes not being active and progressive, but also recognizing improvement may not be permanent.

https://www.diabetes.org/newsroom/press-releases/2021/international-experts-outline-diabetes-remission-diagnosis-criteria

XX

Got lots of comments and questions about some changes noticed on the Dexcom G6 app recently. Turns out, Dexcom has removed what’s called data smoothing from its most recent update. As of August 9th they say

“The Dexcom G6 app used to smooth all but your current reading on your trend graph. With data smoothing, there can be some differences between the G6 reading you see in real time (the white circle) and the G6 readings you see in the past on your graph (black dots). I’m showing a photo here - I’ll post this with the podcast episode for those listening.

 

To avoid these differences, we removed data smoothing from the Dexcom G6 app in the 1.9 release, but the Follow app and Receiver continue to smooth past CGM data. We will remove smoothing in an upcoming Follow app release to match the G6 app, but we don’t plan to remove data smoothing from the Receiver.”

 

These differences don’t affect the real-time glucose data, alarm, or alerts. Honestly, I’m not sure why they’re doing this or why they smoothed in the first place.. but we’ll follow up and try to find out more

XX

Not a lot of answers here, but this is interesting.. apparently, people with type 2 diabetes are unlikely to develop migraines and people who get regular migraines are less likely to develop diabetes. To find out why.. scientists are looking at two small proteins that are linked to migraine and drive production of insulin.

This team from the University of Tennessee says some of the newer treatments for migraines could increase the risk of diabetes because of the use of these proteins. They want to figure out how to prevent that.

 

https://www.fiercebiotech.com/research/mouse-study-shows-how-causes-behind-migraine-pain-can-improve-diabetes-treatment

XX

T1International is out with results of their 2020 global out of pocket cost survey for people with type 1 diabetes.

Worldwide, one out of every four respondents reported having under-used their insulin at least once within the last year due to high cost.

63.2% of participants reported disruption of insulin supplies and 25.3% reported an increase of insulin prices related to the COVID-19 pandemic.

They’ve conducted this survey every two years since 2016, adding additional questions each year. This time, the Results were published as a research paper in the Journal of Diabetes Research and Clinical Practice, linked in the show notes.

https://www.t1international.com/access-survey/

XX

More to come, including news about a rare form of diabetes, but first, I want to tell you about one of our great sponsors who helps make Diabetes Connections possible.

Real Good Foods. Where the mission is Be Real Good

They make nutritious foods - grain free, high in protein, never added sugar and from real ingredients - I was in Target this week and I saw the new Entrée bowls, I bought the Lemon Chicken and the Lasagna. The Lemon chicken was great! It uses hearts of palm pasta instead of regular noodles which I thought sounded odd but really tasted good. They keep adding to the menu line! You can buy online or find a store near you with their locator right on the website. I’ll put a link in the FB comments and as always at d-c dot com.

Back to the news..

XX

This is from the UK but I think it’s an important reminder that there are more than 2 types of diabetes. It’s new plan to discover and treat mono-genetic diabetes. That’s caused by a single gene mutation - although the specific gene affected can differ. The condition occurs in two types, neonatal - which can occur within the first six months of life - and MODY that develops later, often before the age of 25. About 2% of all diabetes cases are thought to be monogenetic.. the National Health System in England is forming a new training and treatment program to make sure these patients received the correct treatment sooner.

https://www.theguardian.com/society/2021/aug/30/nhs-england-to-train-staff-in-all-trusts-to-spot-rare-type-of-diabetes

XX

And finally, thousands of people in the path of Hurricane Ida are still without power and possibly need help getting their medication. I want to make you aware of the Diabetes Disaster Response Coalition (DDRC).

This is a coalition of lots of diabetes groups - if you need immediate help or want to plan for an emergency, they have the resources.

Physicians and health care providers can call 1-314-INSULIN to report diabetes supply shortages and request support.  People with diabetes and their loved ones can call 1-800-DIABETES (800.342.2383) is available to support people with diabetes and their loved ones for more information.

https://diabetesdisasterresponse.org

XX

Please join me wherever you get podcasts for our next episode -Tuesday -  we’re talking to the folks from Walmart about their deal with Novo to sell their own brand of Novolog Insulin.. The episode out right now is with MannKind, makers of Afrezza inhalable insulin.

That’s In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.